medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2017; 16 (2)


A New Paradigm in Gallstones Diseases and Marked Elevation of Transaminases: An Observational Study

Campos S, Silva N, Carvalho A

Idioma: Ingles.
Referencias bibliográficas: 20
Paginas: 285-290
Archivo PDF: 136.30 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Marinho RT. Burden De Hepatologia - Como Vai O Fígado Dos Portugueses. In: Associação Portuguesa de Estudos do Fígado. 2008. http://apef.com.pt/. Accessed September 2012.

  2. Collier J, Bassendine M. How to respond to abnormal liver function tests. Clin Med 2002; 2: 406-9.

  3. Haslett C, Chilvers ER, Boon NA. Davidson’s principles and practice of medicine. 19th Ed. Edinburgh, Churchill Livingstone: 2002.

  4. Kew MC. Serum aminotransferases concentration as evidence of hepatocellular damage. Lancet 2000; 355: 591-2.

  5. Green RM, Flamm S. American Gastroenterological Association Technical Review On The Evaluation Of Liver Chemistry Tests. Gastroenterology 2002; 123: 1367-84.

  6. Ellis G, Goldberg DM, Spooner RJ. Serum Enzyme Tests In Diseases Of The Liver And Biliary Tree. Am J Clin Pathol 1978; 70: 248-58.

  7. Whitehead MW, Hawkes ND, Hainsworth I. A prospective study of the causes of notably raised aspartate aminotransferase of liver origin. Gut 1999; 45: 129-33.

  8. Hall P, Cash J. What is the real function of the liver function tests? Ulster Med J 2012; 81(1): 30-6.

  9. Hayat JO, Loew CJ, Asrress KN. Contrasting liver function test patterns in obstructive jaundice due to biliary structures and stones. Q J Med 2005; 98: 35-40.

  10. De Ritis F, Giuti G, Piccinico F. Biochemical laboratory tests in viral hepatitis and other hepatic diseases. Bull WHO 1965; 32: 59-72.

  11. Adams JT, Clermont GH, Schwartz SI. Serum glutamicoxaloacetic aminotransferases activity in cholecystitis. Surgery 1970; 68: 492-7.

  12. Mayer AD, McMahon MJ. Biochemical identification of patients with gallstones associated with acute pancreatitis on the day of admission to hospital. Ann Surgery 1985; 201: 68-75.

  13. Aragon G, Younossi ZM. When And How To Evaluate Mildly Elevated Liver Enzymes In Apparently Healthy Patients. Clev Clin J Med 2010; 77: 195-204.

  14. European Association for the Study of the Liver. EASL Clinical Practical Guidelines: Management Of Alcoholic Liver Disease. J Hepatol 2012; 57: 399-420.

  15. Fuhrmann V, Jager B, Zubkova A. Hypoxic hepatitis – epidemiology, pathophysiology and clinical management. Wien Klin Wochenschr 2010; 122(5-6): 129-39.

  16. Craxi A, Almasio P. Diagnostic approach to liver enzyme elevation. J Hepatol 1996; 25 Suppl 1: 47-51.

  17. Rodriguez C, Martin L. Estudio diagnóstico del paciente con elevación de las aminotransferases. GH Continuada 2002; 1: 345-8.

  18. Isogai M, Hachisuka K, Yamaguchi A. Etiology and pathogenesis of marked elevation of serum aminotransferases in patients with acute gallstone disease. HPB Surgery 1991; 5: 95-107.

  19. Shaffer EA. Epidemiology and risk factors for gallstone disease: has the paradigm changed in the 21st Century? Best Practice And Research Clinical Gastroenterology 2006; 20: 981-96.

  20. Wasley A. Surveillance For Acute Viral Hepatitis. Morbidity and mortality weekly report. Surveillance Summaries 2008; 57: 1-24.




2020     |     www.medigraphic.com